{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:22:23Z","timestamp":1765977743795,"version":"3.48.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.semradonc.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:42:10Z","timestamp":1765543330000},"page":"114-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiotherapy for Nonmalignant Eye Diseases: Graves\u2019 Ophthalmopathy \u2013 Pseudotumor Orbitae"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-0914","authenticated-orcid":false,"given":"Michael Heinrich","family":"Seegenschmiedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-5986","authenticated-orcid":false,"given":"Gabriele","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2025.11.005_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1992.2.235","article-title":"Classification of eye changes of Graves\u2019 disease","volume":"2","year":"1992","journal-title":"Thyroid."},{"key":"10.1016\/j.semradonc.2025.11.005_bib0002","series-title":"Neueinteilung der Symptome der Endokrinen Orbitopathie","first-page":"77","author":"Boergen","year":"1991"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0003","first-page":"339","article-title":"Therapeutic controversies. Radiation and Graves\u2019 ophthalmopathy","volume":"80","author":"DeGroot","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0004","doi-asserted-by":"crossref","unstructured":"Bartalena L, Veronesi G, Krassas GE, et al. Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves\u2019 ophthalmopathy? J Endocrinol Investig. 2017;40(5):547\u201353.","DOI":"10.1007\/s40618-017-0608-z"},{"issue":"10","key":"10.1016\/j.semradonc.2025.11.005_bib0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0043-116945","article-title":"Combination therapy of intravenous steroids and orbital irradiation is more effective than intravenous steroids alone in patients with Graves\u2019 ophthalmopathy","volume":"49","author":"Oeverhaus","year":"2017","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11547-020-01244-5","article-title":"Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves ophthalmopathy?","volume":"126","author":"Limone","year":"2021","journal-title":"Radiol Med"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajo.2016.08.010","article-title":"The effect of systemic steroids and orbital radiation for active Graves\u2019 disease on post-decompression extraocular muscle volume","volume":"171","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/thy.1998.8.439","article-title":"Orbital radio- therapy for Graves\u2019 ophthalmopathy","volume":"8","author":"Bartalena","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00066-012-0245-6","article-title":"Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques","volume":"189","author":"Brualla","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/0360-3016(87)90346-4","article-title":"Radiation therapy for Graves\u2019 ophthalmopathy: Retrospective analysis","volume":"13","author":"Palmer","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03348485","article-title":"Radio- therapy of severe ophthalmic Graves\u2019 disease","volume":"8","author":"van Ouwerkerk","year":"1985","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"10.1016\/j.semradonc.2025.11.005_bib0012","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1007\/s10792-023-02842-8","article-title":"Changes in therapeutic response, ocular manifestations of Graves' ophthalmopathy and quality of life during the first year after orbital radiotherapy","volume":"43","author":"Stoynova","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.11.005_bib0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rontge.2006.07.002","article-title":"Radiotherapy of Graves\u2019 ophthalmopathy-state of the art and review of the literature","volume":"56","author":"Eich","year":"2007","journal-title":"Rontgenpraxis"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/PL00002338","article-title":"Konventionelle und virtuelle simulation bei der retrobulb\u00e4rbestrahlung","volume":"176","author":"Gripp","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0015","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/0360-3016(85)90088-4","article-title":"Super voltage radiotherapy for Graves\u2019 ophthalmopathy: CCABC technique and results","volume":"11","author":"Olivotto","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0016","first-page":"485","article-title":"Strahlentherapie der endokrinen ophthalmopathie \u2013 auswertung von 56 f\u00e4llen","volume":"160","author":"Uhlenbrock","year":"1984","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0017","first-page":"673","article-title":"Retrobulb\u00e4rbestrahlung bei endokriner ophthalmopathie: Vergleich zwischen 10 und 16 gy herddosis","volume":"166","author":"Pfluger","year":"1990","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00066-012-0269-y","article-title":"Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors","volume":"189","author":"Kocher","year":"2013","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.23736\/S1824-4785.21.03350-1","article-title":"Graves' orbitopathy: A multidisciplinary approach","volume":"65","author":"Limone","year":"2021","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0020","series-title":"Radiation Oncology","article-title":"Radiotherapy for diseases of the eye","author":"Reinartz","year":"2020"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0021","first-page":"102","article-title":"Low versus high dose radiotherapy for Graves ophthalmopathy","volume":"85","author":"Kahaly","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9214","key":"10.1016\/j.semradonc.2025.11.005_bib0022","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves' orbitopathy: Randomized placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.semradonc.2025.11.005_bib0023","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)03795-1","article-title":"Retrobulbar irradiation for thyroid-associated ophthalmopathy: Double- blind comparison between 2.4 and 16 Gy","volume":"55","author":"Gerling","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0025","article-title":"Orbital radiotherapy plus concomitant steroids in moderate-to-severe Graves\u2019 ophthalmopathy: Good results after long-term follow-up","volume":"17","author":"Nicosia","year":"2019","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0026","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03038622","article-title":"Radiotherapie bei progredienter endokriner orbitopathie: Langzeitresultate und klassifikationen im vergleich","volume":"174","author":"Seegenschmiedt","year":"1998","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0027","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0360-3016(89)90073-4","article-title":"Results of radiotherapy for thyroid ophthalmopathy","volume":"17","author":"Sandler","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"10.1016\/j.semradonc.2025.11.005_bib0028","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0360-3016(95)97952-W","article-title":"Mega- voltage radiotherapy for severe and refractory progressive Graves\u2019 ophthalmopathy: Comparison of scoring systems and long-term results","volume":"32","author":"Seegenschmiedt","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systematic corticosteroids for Graves\u2019 ophthalmopathy: A comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomized double-blind trial of prednisone versus radiotherapy in Graves\u2019 ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0031","series-title":"Radiotherapy of Ocular Disease","first-page":"206","article-title":"Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine ophthalmopathy (Graves\u2019 disease)","volume":"30","author":"Staar","year":"1997"},{"issue":"4S Suppl 1","key":"10.1016\/j.semradonc.2025.11.005_bib0032","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/IOP.0000000000001074","article-title":"Radiotherapy for active thyroid eye disease","volume":"34","author":"Godfrey","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.semradonc.2025.11.005_bib0033","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","article-title":"Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2\u202f\u00d7\u202f2 factorial, double-blind, randomised controlled trial","volume":"6","author":"Rajendram","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.semradonc.2025.11.005_bib0034","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: A consensus statement by the American Thyroid Association and the European Thyroid Association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.sjopt.2017.09.003","article-title":"Review of the treatment of Graves\u2019 ophthalmopathy: The role of the new radiation techniques","volume":"32","author":"San Miguel","year":"2018","journal-title":"Saudi J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0036","article-title":"The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0037","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12020-024-03788-2","article-title":"Late orbital radiotherapy combined with i.v. methylprednisolone in management of long-lasting active Graves' ophthalmopathy: Case report and literature review","volume":"85","author":"Verrienti","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0038","first-page":"471","article-title":"Idiopathic Myositis involving the extraocular muscles","volume":"12","author":"Gleason","year":"1903","journal-title":"Opthalmol Rec"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0039","first-page":"127e35","article-title":"Zur diagnostik and pathologie der orbital tumoren","volume":"32","author":"Birch-Hirschfeld","year":"1905","journal-title":"Bericht \u00fcber die Zusammenkunft der Deutschen Ophthalmologischen Gesellschaft"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0030-4220(54)90041-9","article-title":"Pseudo giant cell tumor (reparative granuloma) of the jaw","volume":"7","author":"Umiker","year":"1954","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0041","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s40001-023-01330-0","article-title":"Orbital inflammatory pseudotumor: New advances in diagnosis, pathogenesis, and treatment","volume":"28","author":"Fang","year":"2023","journal-title":"Eur J Med Res"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib0042","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/09273948.2020.1871493","article-title":"The Role of radiotherapy in orbital pseudotumor: A systematic review of literature","volume":"30","author":"Fionda","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0043","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2016.304","article-title":"Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor","volume":"34","author":"Min","year":"2019","journal-title":"Korean J Intern Med"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2003.01.002","article-title":"Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1","volume":"111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0045","unstructured":"Gaillard F, Silverstone L, Sharma R, et al. Idiopathic orbital inflammation. Reference article, Radiopaedia.org 10. 2025 https:\/\/doi.org\/10.53347\/rID-1781 Permalink: https:\/\/radiopaedia.org\/articles\/1781\/rID:1781. Accessed Otober 12, 2025"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0046","doi-asserted-by":"crossref","first-page":"115","DOI":"10.18231\/j.ijooo.2022.024","article-title":"Nonspecific orbital inflammatory disease \u2013 A review article","volume":"8","author":"Brar","year":"2022","journal-title":"IP Int J Ocul Oncol Oculoplasty"},{"issue":"12","key":"10.1016\/j.semradonc.2025.11.005_bib0047","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2007.124156","article-title":"Idiopathic orbital inflammatory syndrome: Clinical features and treatment outcomes","volume":"91","author":"Swamy","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib0048","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0161-6420(97)30300-5","article-title":"Outcome of orbital myositis. Clinical features associated with recurrence","volume":"104","author":"Mannor","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semradonc.2025.11.005_bib0049","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archopht.121.4.491","article-title":"Idiopathic orbital inflammation: Distribution, clinical features, and treatment outcome","volume":"121","author":"Yuen","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0050","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1055\/s-0045-1805011","article-title":"Orbital pseudotumor: Neurosurgical perspective pseudotumor orbit\u00e1rio: Perspectiva neurocir\u00fargica","volume":"44","author":"Karpinski","year":"2025","journal-title":"Arq Bras Neurocir"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0051","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0360-3016(90)90108-V","article-title":"The results of radiotherapy for orbital pseudotumor","volume":"18","author":"Lanciano","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0052","doi-asserted-by":"crossref","unstructured":"Orcutt JC, Garner A, Henk JM, Wright JE. Treatment of idiopathic inflammatory orbital pseudotumor by radiotherapy. Br J Ophthalmol Sep;67(9):570-4. doi: 10.1136\/bjo.67.9.570.","DOI":"10.1136\/bjo.67.9.570"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0053","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1053-4296(99)80008-3","article-title":"Radiation therapy for benign disease of the orbit","volume":"9","author":"Smitt","year":"1999","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib0054","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0161-6420(79)35439-2","article-title":"Radiation treatment of orbital lymphoid hyperplasia","volume":"86","author":"Kennerdell","year":"1979","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archopht.1981.03930010853013","article-title":"Radiotherapy for idiopathic inflammatory orbital pseudotumor. Indications and results","volume":"99","author":"Sergott","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0056","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","article-title":"Orbital cobalt irradiation combined with systemic corticosteroids for Graves\u2019 ophthalmopathy: Comparison with systemic corticosteroids alone","volume":"56","author":"Bartalena","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0057","first-page":"163","article-title":"Corticoid- und strahlentherapie bei endokriner orbitopathie","volume":"18","author":"Esser","year":"1995","journal-title":"Nuklearmed"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0058","series-title":"Radiotherapy of Ocular Disease","first-page":"206","article-title":"Clinical importance of radiotherapy in the treatment of Graves\u2019 disease","volume":"30","author":"Friedrich","year":"1997"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0059","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0002-9394(14)76027-1","article-title":"Radiation therapy for thyroid eye diseases","volume":"99","author":"Hurbli","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1507\/endocrj1954.33.637","article-title":"Clinical evaluation of radiotherapy for Graves\u2019 ophthalmopathy","volume":"33","author":"Konishi","year":"1986","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0061","first-page":"154","article-title":"Super voltage orbital radiotherapy for progressive Graves\u2019 ophthalmopathy: Results of a twenty-year experience","volume":"121","author":"Kriss","year":"1989","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0062","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(90)90532-O","article-title":"Prognostic factors in the radiotherapy of Graves\u2019 ophthalmopathy","volume":"19","author":"Petersen","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0063","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(14)76158-6","article-title":"Super voltage orbital radiotherapy in 36 cases of Graves\u2019 disease","volume":"113","author":"Lloyd","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0064","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000180697","article-title":"High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves\u2019 ophthalmopathy","volume":"26","author":"Pigeon","year":"1987","journal-title":"Horm Res"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9394(75)90083-5","article-title":"Orbital radiation for the ocular changes of Graves\u2019 disease","volume":"79","author":"Ravin","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0066","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1980.tb03422.x","article-title":"An evaluation of super voltage orbital irradiation for Graves\u2019 ophthalmopathy","volume":"13","author":"Teng","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0067","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000309924","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves\u2019 ophthalmopathy","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0068","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/archopht.1995.01100110080029","article-title":"Radiotherapy for thyroid ophthalmopathy","volume":"113","author":"Wilson","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1046403","article-title":"Die Rolle der Strahlentherapie bei der endokrinen Orbitopathie [The role of radiotherapy in endocrine orbitopathy]","volume":"195","author":"Feyerabend","year":"1989","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib0070","first-page":"305","article-title":"Ergebnisse der Retrobulb\u00e4rbestrahlung bei benigner endokriner Ophthalmopathie [Results of retrobulbar irradiation in case of benign endocrinous ophthalmopathy (author's transl)]","volume":"157","author":"Fritsch","year":"1981","journal-title":"Strahlentherapie"},{"issue":"7","key":"10.1016\/j.semradonc.2025.11.005_bib0071","first-page":"469","article-title":"Zur Strahlentherapie der endokrinen Orbitopathie. 1. Mitteilung: Klinische Ergebnisse [Radiation therapy of endocrine orbitopathy. 1st communication: clinical results (author's transl)]","volume":"156","author":"Grauthoff","year":"1980","journal-title":"Strahlentherapie"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib0072","first-page":"226","article-title":"Strahlentherapie der endokrinen Ophthalmopathie mit 18-MeV-Bremsstrahlung [Radiotherapy of endocrine ophthalmopathy using 18-MeV betatron radiation]","volume":"148","author":"Heinze","year":"1974","journal-title":"Strahlentherapie"},{"issue":"11","key":"10.1016\/j.semradonc.2025.11.005_bib0073","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2008-1069569","article-title":"Endokrine Orbitopathie. Therapieerfolge bei 148 Patienten unter Ber\u00fccksichtigung neuer pathogenetischer Aspekte [Endocrine orbitopathy. Results of therapy in patients with reference to new pathogenetic aspects]","volume":"108","author":"Horster","year":"1983","journal-title":"Dtsch Med Wochenschr"},{"issue":"44","key":"10.1016\/j.semradonc.2025.11.005_bib0074","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1055\/s-0028-1107636","article-title":"Zur Therapie der endokrinen Ophthalmopathie [Therapy of endocrine ophthalmopathy]","volume":"97","author":"Wildmeister","year":"1972","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.semradonc.2025.11.005_bib0075","first-page":"71","article-title":"Orbital irradiation in the treatment of Graves' ophthalmopathy","volume":"226","author":"Bartalena","year":"1988","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib0076","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves' ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.semradonc.2025.11.005_bib0077","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03347943","article-title":"Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study","volume":"14","author":"Marcocci","year":"1991","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.semradonc.2025.11.005_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0360-3016(85)90160-9","article-title":"Radiotherapy of lymphoid diseases of the orbit","volume":"11","author":"Austin-Seymour","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0360-3016(80)90207-2","article-title":"Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy","volume":"6","author":"Donaldson","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.11.005_bib3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00234-018-2103-4","article-title":"CT and MR imaging of orbital inflammation","volume":"60","author":"Ferreira","year":"2018","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","article-title":"Lymphoreticular tumors of the orbit","volume":"10","author":"Fitzpatrick","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiology.159.3.3085143","article-title":"Orbital lymphomas and pseudolymphomas: Treatment with radiation therapy","volume":"159","author":"Gordon","year":"1986","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.semradonc.2025.11.005_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0360-3016(84)90172-X","article-title":"Radiation therapy of conjunctival and orbital lymphoid tumors","volume":"10","author":"Jereb","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijrobp.2011.11.031","article-title":"Radiotherapy with or without surgery for patients with idiopathic sclerosing orbital inflammation refractory or intolerant to steroid therapy","volume":"84","author":"Lee","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.semradonc.2025.11.005_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0161-6420(85)33854-X","article-title":"Treatment protocol for orbital inflammatory disease","volume":"92","author":"Leone","year":"1985","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semradonc.2025.11.005_bib9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2009.12.071","article-title":"The efficacy of radiotherapy in the treatment of orbital pseudotumor","volume":"79","author":"Matthiesen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiology.159.3.3704159","article-title":"Para ocular lymphoid tumors","volume":"159","author":"Mittal","year":"1986","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.semradonc.2025.11.005_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/07357907.2018.1489550","article-title":"Radiotherapy for orbital pseudotumor: The university of Florida experience","volume":"36","author":"Mokhtech","year":"2018","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semradonc.2025.11.005_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000425703","article-title":"Radiotherapy of pseudotumor orbitae","volume":"30","author":"Notter","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijrobp.2012.06.033","article-title":"Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy","volume":"85","author":"Prabhu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2025.11.005_bib14","first-page":"198","article-title":"Efficient treatment of resistant orbital pseudotumor with cyberknife: Case series and short review of literature","volume":"29","author":"Yaprak","year":"2018","journal-title":"South Clin Ist Euras"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962500089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962500089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:18:41Z","timestamp":1765977521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105342962500089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":91,"alternative-id":["S105342962500089X"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.11.005","relation":{},"ISSN":["1053-4296"],"issn-type":[{"type":"print","value":"1053-4296"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for Nonmalignant Eye Diseases: Graves\u2019 Ophthalmopathy \u2013 Pseudotumor Orbitae","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}